New Zealand
New Zealand’s HIV tests market set for growth at 2% CAGR until 2033
EIA tests accounted for around 49% of the country’s HIV test market in 2023.
3 days ago
New Zealand’s HIV tests market set for growth at 2% CAGR until 2033
EIA tests accounted for around 49% of the country’s HIV test market in 2023.
3 days ago
New Zealand’s medicines budget to boost R&D-based drugmakers
But Fitch Solutions’ report noted that allocation for medicine investment remains low.
New Zealand rolls out health system reforms
Its healthcare system was criticized over variable access across districts.
Private operator Healthscope sells New Zealand pathology business for $364m
Customary approval is expected to be completed within the next six months.
Most Read
1. SGH and NNI study reveals connection between scoliosis and brainstem 2. Why rare disease policies are critical to ensure equitable access to treatment for rare disease communities in Southeast Asia 3. 3 in 5 novice nurses struggle with higher-complexity procedures 4. Synpaxe, tech giants foster GenAI in healthcare 5. Pureland Venture Partner Chris Hardesty champions accessibility, impact, and collaboration in healthcareResource Center
Read Here
Advertise
Sign Up
Event News
Event News
Discover cutting-edge strategies reshaping healthcare delivery with EY’s Abhay Bangi
![Discover cutting-edge strategies reshaping healthcare delivery with EY’s Abhay Bangi]()
Co-Written / Partner
Explore the complexities of the healthcare landscape, as well as innovation and transformation within the sector, guided by the EY expert’s visionary insights.
Explore the complexities of the healthcare landscape, as well as innovation and transformation within the sector, guided by the EY expert’s visionary insights.
